[1]
Iivanainen, S. et al. 2020. Predicting Onset and Continuity of Patient-Reported Symptoms in Patients Receiving Immune Checkpoint Inhibitor (ICI) Therapies Using Machine Learning. Archives of Clinical and Medical Case Reports. 4, 3 (May 2020), 344–351.